GCA
CLB icon

Greenwood Capital Associates’s Core Laboratories CLB Stock Holding History

Greenwood Capital Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,870
Closed -$217K – 171
2018
Q3 		$217K Hold
1,870
– – 0.05% 175
2018
Q2 		$236K Buy
+1,870
New +$228K 0.05% 173

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Greenwood Capital Associates's CLB Position: Q4 2018 in Review

Greenwood Capital Associates sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 1,870 shares — an estimated $217K sold.

Greenwood Capital Associates first reported a position in CLB in Q2 2018 and held it in 2 quarters. The position peaked at $236K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Greenwood Capital Associates reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Greenwood Capital Associates sold 1,870 Core Laboratories shares in Q4 2018, an estimated $217K.
  • Greenwood Capital Associates first reported a position in Core Laboratories in Q2 2018 and held it in 2 quarters.
  • Greenwood Capital Associates's Core Laboratories position peaked at $236K in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Greenwood Capital Associates's 13F filing for Q4 2018, filed 11 Feb 2019.